RaySearch Laboratories AB (OSTO:RAY B) Total Liabilities : kr1,214 Mil (As of Dec. 2024)

View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Total Liabilities?

RaySearch Laboratories AB's Total Liabilities for the quarter that ended in Dec. 2024 was kr1,214 Mil.

RaySearch Laboratories AB's quarterly Total Liabilities declined from Jun. 2024 (kr1,293.28 Mil) to Sep. 2024 (kr1,204.84 Mil) but then increased from Sep. 2024 (kr1,204.84 Mil) to Dec. 2024 (kr1,214.48 Mil).

RaySearch Laboratories AB's annual Total Liabilities declined from Dec. 2022 (kr1,218.79 Mil) to Dec. 2023 (kr1,217.43 Mil) and declined from Dec. 2023 (kr1,217.43 Mil) to Dec. 2024 (kr1,214.48 Mil).

RaySearch Laboratories AB Total Liabilities Historical Data

The historical data trend for RaySearch Laboratories AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Total Liabilities Chart

RaySearch Laboratories AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

590.55

1,116.43

1,218.79

1,217.43

1,214.48

RaySearch Laboratories AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															1,217.43	1,287.66	1,293.28	1,204.84	1,214.48

RaySearch Laboratories AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

RaySearch Laboratories AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	703.82	+	(394.855	+	115.802
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1,214

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2091.184	-	876.707
	=	1,214

RaySearch Laboratories AB's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	703.82	+	(394.855	+	115.802
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	1,214

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	2091.184	-	876.707
	=	1,214

RaySearch Laboratories AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

RaySearch Laboratories AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

RSLBF:USA RAYBs:UK 0GRZ:UK 27R:Germany

Address

Eugeniavagen 18C, P.O. Box 3297, Stockholm, SWE, 113 68

Website

https://www.raysearchlabs.com

RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB Headlines

No Headlines